Correlation Between Bellevue Gold and Bio Gene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bellevue Gold and Bio Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bellevue Gold and Bio Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bellevue Gold and Bio Gene Technology, you can compare the effects of market volatilities on Bellevue Gold and Bio Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bellevue Gold with a short position of Bio Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bellevue Gold and Bio Gene.

Diversification Opportunities for Bellevue Gold and Bio Gene

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Bellevue and Bio is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Bellevue Gold and Bio Gene Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Gene Technology and Bellevue Gold is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bellevue Gold are associated (or correlated) with Bio Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Gene Technology has no effect on the direction of Bellevue Gold i.e., Bellevue Gold and Bio Gene go up and down completely randomly.

Pair Corralation between Bellevue Gold and Bio Gene

Assuming the 90 days trading horizon Bellevue Gold is expected to under-perform the Bio Gene. But the stock apears to be less risky and, when comparing its historical volatility, Bellevue Gold is 2.01 times less risky than Bio Gene. The stock trades about -0.36 of its potential returns per unit of risk. The Bio Gene Technology is currently generating about -0.12 of returns per unit of risk over similar time horizon. If you would invest  5.30  in Bio Gene Technology on September 1, 2024 and sell it today you would lose (0.90) from holding Bio Gene Technology or give up 16.98% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.65%
ValuesDaily Returns

Bellevue Gold  vs.  Bio Gene Technology

 Performance 
       Timeline  
Bellevue Gold 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bellevue Gold are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain essential indicators, Bellevue Gold may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Bio Gene Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Bio Gene is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Bellevue Gold and Bio Gene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bellevue Gold and Bio Gene

The main advantage of trading using opposite Bellevue Gold and Bio Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bellevue Gold position performs unexpectedly, Bio Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Gene will offset losses from the drop in Bio Gene's long position.
The idea behind Bellevue Gold and Bio Gene Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites